Greenlane Stock Price, News & Analysis (NASDAQ:GNLN)

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GNLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNLN, but not buy additional shares or sell existing shares.
View GNLN analyst ratings or view top-rated stocks.

Greenlane's stock was trading at $2.8750 at the beginning of the year. Since then, GNLN shares have decreased by 80.2% and is now trading at $0.5699.
View the best growth stocks for 2023 here.

Greenlane saw a decrease in short interest in November. As of November 15th, there was short interest totaling 25,100 shares, a decrease of 66.4% from the October 31st total of 74,600 shares. Based on an average daily trading volume, of 77,200 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.0% of the shares of the company are short sold.
View Greenlane's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 5th 2023.
View our GNLN earnings forecast.

Greenlane Holdings, Inc. (NASDAQ:GNLN) posted its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing analysts' consensus estimates of ($14.00) by $32.00. The firm had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million. Greenlane had a negative net margin of 115.75% and a negative trailing twelve-month return on equity of 122.08%. During the same period last year, the business posted ($92.00) EPS.

ETFs with the largest weight of Greenlane (NASDAQ:GNLN) stock in their portfolio include AXS Cannabis ETF (THCX) and Amplify Seymour Cannabis ETF (CNBS).Cambria Cannabis ETF (TOKE).

Greenlane's stock reverse split before market open on Tuesday, June 6th 2023. The 1-10 reverse split was announced on Tuesday, June 6th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include KushCo (KSHB), Organigram (OGI), Enerplus (ERF), Matinas BioPharma (MTNB), Supreme Cannabis (SPRWF), ADMA Biologics (ADMA), EnLink Midstream (ENLC), Gran Tierra Energy (GTE), MariMed (MRMD) and Novan (NOVN).

(GNLN) raised $80 million in an initial public offering on Thursday, April 18th 2019. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Greenlane's stock is owned by many different retail and institutional investors. Top institutional shareholders include Armistice Capital LLC (12.37%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Locascio, Adam Schoenfeld, Craig A Snyder and William E Mote Jr.
View institutional ownership trends.

Shares of GNLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.